The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use,
Recital 4, Decision_act (EU) 2026/334
In forcesince 13 Feb 2026
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use,